Biomeme and Indical bring mobile diagnostics solutions to animal health & food production sectors through exclusive partnership

May 20, 2019

Biomeme and Indical enters into an exclusive global licensing and research agreement in a joint effort to improve animal health globally.

Biomeme has developed an advanced mobile PCR detection technology that solves time-sensitive and location-sensitive problems where results need to be in real-time. Indical, with twenty years of experience animal diagnostics, will adapt the molecular point-of-need testing for veterinary applications and offer its suite of molecular and immunological testing solutions.

Read more about the exclusive partnership here.

Recent news

First day of trading in Vimian’s shares on …

Vimian Group AB (publ) (“Vimian”, the “Group” or the “Company”), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, today announces the listing of and commencement

Read more

Vimian announces intention to list on Nasdaq Firs…

Vimian Group AB (publ), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, announces its intention to carry out a private placement of shares in the

Read more

Fidelio forms Vimian – a global powerhouse …

Following a decade of successfully shaping market leaders across the rapidly evolving animal health market, Fidelio Capital AB (Fidelio) today announced the formation of Vimian – a global and diversified group of innovation-driven companies operating in four fast-growing animal health

Read more